Intec Parent Inc (NTEC) Fundamental Analysis & Valuation

NASDAQ:NTEC

Current stock price

9.63
-1.37 (-12.48%)
At close:
9.9
+0.27 (+2.8%)
After Hours:

This NTEC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NTEC Profitability Analysis

1.1 Basic Checks

  • NTEC had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -83.12%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NTEC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. NTEC Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for NTEC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • Based on the Altman-Z score of -18.11, we must say that NTEC is in the distress zone and has some risk of bankruptcy.
  • NTEC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.11
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 2.34 indicates that NTEC has no problem at all paying its short term obligations.
  • A Quick Ratio of 2.34 indicates that NTEC has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34

1

3. NTEC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 80.45% over the past year.
EPS 1Y (TTM)80.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 9.23% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y174.75%
EPS Next 2Y17.79%
EPS Next 3Y18.23%
EPS Next 5Y9.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NTEC Yearly Revenue VS EstimatesNTEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2019 2021 5M 10M 15M 20M 25M
NTEC Yearly EPS VS EstimatesNTEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

0

4. NTEC Valuation Analysis

4.1 Price/Earnings Ratio

  • NTEC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NTEC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTEC Price Earnings VS Forward Price EarningsNTEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.19
NTEC Per share dataNTEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NTEC's earnings are expected to grow with 18.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.79%
EPS Next 3Y18.23%

0

5. NTEC Dividend Analysis

5.1 Amount

  • No dividends for NTEC!.
Industry RankSector Rank
Dividend Yield N/A

NTEC Fundamentals: All Metrics, Ratios and Statistics

Intec Parent Inc

NASDAQ:NTEC (8/3/2021, 8:09:11 PM)

After market: 9.9 +0.27 (+2.8%)

9.63

-1.37 (-12.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners22.37%
Inst Owner Change-3.29%
Ins Owners514.2%
Ins Owner Change0%
Market Cap8.65M
Revenue(TTM)N/A
Net Income(TTM)-14.49M
Analysts73.4
Price Target53.04 (450.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB N/A
EV/EBITDA 0.19
EPS(TTM)-3.44
EYN/A
EPS(NY)-2.5
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS12.63
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -83.12%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z -18.11
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y174.75%
EPS Next 2Y17.79%
EPS Next 3Y18.23%
EPS Next 5Y9.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Intec Parent Inc / NTEC Fundamental Analysis FAQ

What is the fundamental rating for NTEC stock?

ChartMill assigns a fundamental rating of 2 / 10 to NTEC.


What is the valuation status of Intec Parent Inc (NTEC) stock?

ChartMill assigns a valuation rating of 3 / 10 to Intec Parent Inc (NTEC). This can be considered as Overvalued.


How profitable is Intec Parent Inc (NTEC) stock?

Intec Parent Inc (NTEC) has a profitability rating of 1 / 10.


How financially healthy is Intec Parent Inc?

The financial health rating of Intec Parent Inc (NTEC) is 2 / 10.